Intracranial Abscess Treatment Market size is set to register over 17.9% CAGR during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the increasing prevalence of intracranial abscess, backed by increasing head injuries, and neurosurgeries. Intracranial abscess refers to collection of pus between the brain and skull. This blocks the flow of blood to the brain, which, in turn, limits the supply of oxygen to that part of the brain, resulting to impairment of speech and hearing, coordination and movement troubles, disturbed consciousness, and even paralysis. The pus is generated when any infection reaches the brain, which can be through ear, teeth, throat, or directly through head during a surgery. The rising cases of road accidents, that cause head injuries, and as a result, require a surgery, are estimated to drive the market growth. According to the data by the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents. The mounting prevalence of cerebrovascular diseases, and neurological diseases, such as, Parkinson’s disease, dementia, cerebral infarction, and others, is also projected to boost the intracranial abscess treatment market growth.
Growth Drivers
Challenges
2023 |
|
Forecast Year |
2024–2036 |
CAGR |
17.9% |
Regional Scope |
|
The market is segmented by origin into ear infection, chronic sinusitis, neurosurgery, head injury, and others, out of which, the head injury segment is anticipated to hold the notable share in the intracranial abscess treatment market over the forecast period on account of rising cases of severe head injuries, most of which are caused in road accidents, falls, or other traumatic accidents. Mostly, these injuries become the source of infection inside the skull, which, as a result, cause intracranial abscess.
Our in-depth analysis of the global market includes the following segments:
By Origin |
|
By Diagnosis |
|
By Treatment |
|
End-User |
|
On the basis of geographical analysis, the intracranial abscess treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific is estimated to account for largest revenue share by 2036, on the back of high cases of injuries, and accidents, along with growing healthcare system in the developing countries.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period high healthcare expenditure, and presence of major pharmaceutical companies. According to the statistics by the World Bank, the total healthcare expenditure of North America accounted for 16.415% of the total GDP, in 2018. Increasing research activities for the development of new drugs is also estimated to boost the intracranial abscess treatment market growth.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?